These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15113884)
1. Activation of adenoviral gene expression by protein IX is not required for efficient virus replication. Sargent KL; Meulenbroek RA; Parks RJ J Virol; 2004 May; 78(10):5032-7. PubMed ID: 15113884 [TBL] [Abstract][Full Text] [Related]
2. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors. Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222 [TBL] [Abstract][Full Text] [Related]
3. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Krougliak V; Graham FL Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382 [TBL] [Abstract][Full Text] [Related]
4. Insertion of an exogenous promoter in the E1A regulatory region of adenovirus does not disturb viral replication despite reduced E1A transcription. Yu L; Hamada K; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Tagawa M Cancer Lett; 2004 Jan; 203(1):51-7. PubMed ID: 14670617 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus. Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus protein IX: a new look at an old protein. Parks RJ Mol Ther; 2005 Jan; 11(1):19-25. PubMed ID: 15585402 [TBL] [Abstract][Full Text] [Related]
7. Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment. Hoffmann D; Wildner O Mol Cancer Ther; 2006 Feb; 5(2):374-81. PubMed ID: 16505112 [TBL] [Abstract][Full Text] [Related]
8. The product of the adenovirus intermediate gene IX is a transcriptional activator. Lutz P; Rosa-Calatrava M; Kedinger C J Virol; 1997 Jul; 71(7):5102-9. PubMed ID: 9188576 [TBL] [Abstract][Full Text] [Related]
9. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma. Liu Y; Ye T; Sun D; Maynard J; Deisseroth A Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524 [TBL] [Abstract][Full Text] [Related]
10. A system for efficient generation of adenovirus protein IX-producing helper cell lines. Vellinga J; Uil TG; de Vrij J; Rabelink MJ; Lindholm L; Hoeben RC J Gene Med; 2006 Feb; 8(2):147-54. PubMed ID: 16288495 [TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis. Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242 [TBL] [Abstract][Full Text] [Related]
12. Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP. Meulenbroek RA; Sargent KL; Lunde J; Jasmin BJ; Parks RJ Mol Ther; 2004 Apr; 9(4):617-24. PubMed ID: 15093192 [TBL] [Abstract][Full Text] [Related]
13. Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity. Poulin KL; McFall ER; Chan G; Provost NB; Christou C; Smith AC; Parks RJ J Virol; 2020 Aug; 94(17):. PubMed ID: 32522855 [TBL] [Abstract][Full Text] [Related]
14. A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors. Hernandez-Alcoceba R; Pihalja M; Wicha MS; Clarke MF Hum Gene Ther; 2000 Sep; 11(14):2009-24. PubMed ID: 11020800 [TBL] [Abstract][Full Text] [Related]
15. Construction of a novel oncolytic adenoviral vector and its biological characteristics. Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. Schreiner S; Martinez R; Groitl P; Rayne F; Vaillant R; Wimmer P; Bossis G; Sternsdorf T; Marcinowski L; Ruzsics Z; Dobner T; Wodrich H PLoS Pathog; 2012 Feb; 8(2):e1002549. PubMed ID: 22427750 [TBL] [Abstract][Full Text] [Related]
17. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species. Eloit M; Adam M J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365 [TBL] [Abstract][Full Text] [Related]
18. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914 [TBL] [Abstract][Full Text] [Related]
19. New tools for the construction of replication-competent adenoviral vectors with altered E1A regulation. Avvakumov N; Mymryk JS J Virol Methods; 2002 May; 103(1):41-9. PubMed ID: 11906731 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes. Yamauchi S; Zhong B; Kawamura K; Yang S; Kubo S; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M BMC Cancer; 2017 Sep; 17(1):622. PubMed ID: 28874135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]